Docoh
Loading...

TARO Taro Pharmaceutical Industries

Taro Pharmaceutical Industries Ltd. is engaged in the development, manufacturing, and marketing of prescribed and over-the-counter pharmaceutical products in the U.S., Canada, and Israel. Its products include semi-solids formulations, such as creams and ointments and other dosage forms such as liquids, capsules and tablets, in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. The company was founded in 1950 and is headquartered in Haifa Bay, Israel.

Company profile

TARO stock data

(
)

Calendar

19 Jun 20
13 Apr 21
31 Mar 22
Quarter (USD)
Mar 12
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Mar 20 Mar 19 Mar 18 Mar 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

13.2% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 83 76 +9.2%
Opened positions 17 5 +240.0%
Closed positions 10 11 -9.1%
Increased positions 26 28 -7.1%
Reduced positions 22 24 -8.3%
13F shares
Current Prev Q Change
Total value 369.03M 254.82M +44.8%
Total shares 5.03M 4.66M +8.1%
Total puts 0 10K EXIT
Total calls 0 0
Total put/call ratio Infinity
Largest owners
Shares Value Change
Renaissance Technologies 785.1K $57.64M +2.1%
FMR 678.74K $49.83M +1.3%
Krensavage Asset Management 553.65K $40.65M +3.0%
Dimensional Fund Advisors 478.99K $35.17M +1.0%
Brandes Investment Partners 412.21K $29.8M +20.6%
Acadian Asset Management 368.52K $27.06M -1.4%
NTRS Northern Trust 198.54K $14.58M +3.7%
Eversept Partners 152.26K $11.18M +7.3%
IVZ Invesco 152.24K $11.18M -9.7%
BLK Blackrock 150.77K $11.07M +10399.5%
Largest transactions
Shares Bought/sold Change
BLK Blackrock 150.77K +149.34K +10399.5%
Norges Bank 118.75K +118.75K NEW
APG Asset Management 0 -76.21K EXIT
Brandes Investment Partners 412.21K +70.44K +20.6%
AMP Ameriprise Financial 82.17K +68.71K +510.7%
UBS UBS Group AG - Registered Shares 5.78K -62.39K -91.5%
Point72 Asset Management 42K +42K NEW
STT State Street 37.77K +30.54K +422.6%
Citadel Advisors 22.38K -27.52K -55.2%
Arrowstreet Capital, Limited Partnership 0 -23.61K EXIT

Financial report summary

?
Competition
AkornTeligent
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. freshman Avg
New words: absorbed, academia, Academy, AFS, Aid, Alpha, amenable, Anatomic, Archemix, Australia, Baruch, behavior, Beta, Biocapital, Biology, biotech, border, Bridgewater, carryback, centralized, centralizing, Chase, Chemtech, claimant, Clocortolone, closure, cloud, communicable, constant, corruption, Daphne, defeated, defense, Dipropionate, distancing, doctorate, Dohme, Duke, DuPont, embedded, encryption, endpoint, Erik, EVP, Excellence, farm, FleetBoston, Fulbright, GE, Geron, Harvard, home, Honor, honorary, HSBC, Huang, Humanwell, IIC, IMA, Incyte, Indiana, Indore, inhibit, Inline, inquiry, Interactive, interchangeable, Internship, intervention, IRP, Kappa, Kinemed, landscape, learning, Leonard, Lifetime, Ligand, lung, magnitude, Melbourne, memorialized, Merit, mobile, Monash, monoclonal, Morgan, movement, MRR, Mupirocin, NaN, Ohio, Omega, Oncology, opioid, outbreak, outflow, Palo, pandemic, Pathology, perception, persist, Phi, Physiology, Pivalate, PRIORTECH, Protagenic, Puracap, rationalization, Relief, remittance, resolve, Robert, Roche, Roivant, RRSP, Samsara, Scholar, Scholarship, session, seventeen, Sharpe, Sigma, sixteen, slower, Society, specialist, speed, spread, spreading, Stein, stop, strain, Supreme, Syntex, tank, tied, unaudited, unconstitutional, undertook, unemployment, Unprecedented, vastly, widespread, XBRL, Xi, Zwicker
Removed: Adapalene, Agur, Aluminum, amalgamation, announcing, Argentina, Balaguer, Ballantine, Biopharma, carbamazepine, cetirizine, Clobetasol, Clomipramine, clorazepate, closing, comparability, Covington, Crescita, Cuyo, de, Desonide, Dewey, dichlorphenamide, dipotassium, Econazole, effecting, Elhanan, Elli, Esq, etodolac, extinguishment, fluocinonide, France, Henry, hereditary, hyperkalemic, hypokalemic, imposition, influencing, introductory, Italy, ITGI, Kennedy, lamotrigine, mandate, Manzano, Mariano, muscle, Nacional, naftifine, NCR, nitrate, Notably, Nutrition, orphan, oxiconazole, predominance, prepayment, Propionate, rare, Retalix, rolling, Schein, securitization, Shigamab, slightly, Stephen, Streit, Strongbridge, terbinafine, Thallion, threat, TP, Universidad, upfront, veterinary, VP, warfarin, Weizmann, Wharton, Yeda

Proxies

No filings